Working Group on the Re-evaluation of the incidence and prophylaxis of HDN in Italy, Research and Development Area, Italian Society of Transfusion Medicine and Immunohaematology.
Blood Transfus. 2007 Jan;5(1):7-14. doi: 10.2450/2007.0018-06.
The Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) carried out a survey on the current use of anti-D immunoprophylaxis (IP) in Italy, on its ways of use and on the impact that it has had on decreasing haemolytic disease of the newborn (HDN), due to maternal-foetal incompatibility for the D antigen.
The survey was carried out using a questionnaire prepared by the Working Group established for this purpose by the SIMTI. The questions were divided into five groups: the ways of carrying out IP, evaluation of foetal-maternal haemorrhage, serological tests after IP, the current incidence of HDN, and data on exchange transfusions.
Data were obtained from 69 Transfusion Services (TS). Four of these give IP antenatally, whereas in the remaining cases IP is given after birth. Almost all the TS evaluate the amount of foetal-maternal haemorrhage in order to give additional doses of anti-D IgG, with the most widely used method being the Kleihauer-Betke test. Data were collected from 176,010 pregnancies: 18,639 were D-negative women, of whom 18,440 were not immunised. There were 136 cases of HDN with anti-D antibodies, and 39 of these required exchange transfusions (ET). Furthermore, there were 1,535 pregnant women with anti-A and/or anti-B IgG, which were clinically significant in 83 and required ET in 37. Finally, 40 women had antibodies, directly related to the pregnancy, against antigens other than D (in eight of these cases ET was necessary).
The survey carried out by SIMTI was able to give a sufficiently full and accurate picture of current Italian practices concerning the use and ways of use of anti-D IP in pregnancy and the puerperum, as well as the incidence and characteristics of HDN. Furthermore, this survey was the basis for guidelines on the management of HDN, produced by SIMTI in collaboration with the Italian Society of Obstetricians and Gynaecologists.
意大利输血医学和免疫血液学学会(SIMTI)就意大利目前抗 D 免疫预防(IP)的使用方式、使用途径以及其对减少因 D 抗原母婴不相容导致的新生儿溶血病(HDN)的影响进行了调查。
该调查采用了 SIMTI 为此目的成立的工作组制定的问卷。问题分为五组:IP 的实施方式、胎儿-母体出血评估、IP 后的血清学检测、HDN 的当前发生率以及换血治疗的数据。
从 69 个输血服务机构(TS)获得了数据。其中 4 个机构在产前给予 IP,而其余机构则在产后给予 IP。几乎所有的 TS 都评估胎儿-母体出血的量,以给予额外剂量的抗 D IgG,最广泛使用的方法是 Kleihauer-Betke 检测。从 176010 例妊娠中收集了数据:18639 例为 D 阴性妇女,其中 18440 例未进行免疫接种。有 136 例抗-D 抗体引起的 HDN,其中 39 例需要换血治疗(ET)。此外,有 1535 例孕妇有抗-A 和/或抗-B IgG,其中 83 例有临床意义,37 例需要 ET。最后,有 40 名妇女因与妊娠直接相关而产生针对除 D 以外的抗原的抗体(在这 8 例中需要 ET)。
SIMTI 进行的调查能够充分、准确地描述意大利目前在妊娠和产褥期使用抗-D IP 的方式和方法,以及 HDN 的发生率和特征。此外,该调查为 SIMTI 与意大利妇产科医生学会合作制定的 HDN 管理指南提供了基础。